{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T10:26:46Z","timestamp":1786876006005,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,16]]},"DOI":"10.7759\/cureus.114592","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T10:20:43Z","timestamp":1786875643000},"source":"Crossref","is-referenced-by-count":0,"title":["Checkerboard Insights: Diagnostic Integration of Synergy Testing for Multidrug-Resistant Klebsiella Isolates in Critical Care"],"prefix":"10.7759","author":[{"given":"Geetika","family":"Nautiyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasha","family":"Mukim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.11.4.589","article-title":"Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors","volume":"11","author":"Podschun R","year":"1998","unstructured":"Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998, 11:589-603. 10.1128\/CMR.11.4.589","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1017\/s0195941700062603","article-title":"Habitat association of Klebsiella species","volume":"6","author":"Bagley ST","year":"1985","unstructured":"Bagley ST. Habitat association of Klebsiella species. Infect Control. 1985, 6:52-8. 10.1017\/s0195941700062603","journal-title":"Infect Control"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00078-15","article-title":"Klebsiella pneumoniae: going on the offense with a strong defense","volume":"80","author":"Paczosa MK","year":"2016","unstructured":"Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016, 80:629-61. 10.1128\/MMBR.00078-15","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00004","article-title":"Colonization, infection, and the accessory genome of Klebsiella pneumoniae","volume":"8","author":"Martin RM","year":"2018","unstructured":"Martin RM, Bachman MA. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front Cell Infect Microbiol. 2018, 8:4. 10.3389\/fcimb.2018.00004","journal-title":"Front Cell Infect Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis LS","year":"2012","unstructured":"Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012, 25:682-707. 10.1128\/CMR.05035-11","journal-title":"Clin Microbiol Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.05.016","article-title":"Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients","volume":"32","author":"Falagas ME","year":"2008","unstructured":"Falagas ME, Rafailidis PI, Matthaiou DK, Virtzili S, Nikita D, Michalopoulos A. Pandrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii infections: characteristics and outcome in a series of 28 patients. Int J Antimicrob Agents. 2008, 32:450-4. 10.1016\/j.ijantimicag.2008.05.016","journal-title":"Int J Antimicrob Agents"},{"key":"ref7","unstructured":"World Health Organization. Empowered communities to tackle antimicrobial resistance. (2024). Accessed. July 30, 2025: https:\/\/www.who.int\/news\/item\/16-11-2024-empowered-communities-to-tackle-antimicrobial-resistance."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens3030743","article-title":"Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae","volume":"3","author":"Vuotto C","year":"2014","unstructured":"Vuotto C, Longo F, Balice MP, Donelli G, Varaldo PE. Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens. 2014, 3:743-58. 10.3390\/pathogens3030743","journal-title":"Pathogens"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.05041-11","article-title":"Combination therapy for treatment of infections with gram-negative bacteria","volume":"25","author":"Tamma PD","year":"2012","unstructured":"Tamma PD, Cosgrove SE, Maragakis LL. Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev. 2012, 25:450-70. 10.1128\/CMR.05041-11","journal-title":"Clin Microbiol Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos AP","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al.. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012, 18:268-81. 10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds FC","year":"2003","unstructured":"Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003, 52:1. 10.1093\/jac\/dkg301","journal-title":"J Antimicrob Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00035-06","article-title":"Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa","volume":"50","author":"Bergen PJ","year":"2006","unstructured":"Bergen PJ, Li J, Rayner CR, Nation RL. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2006, 50:1953-8. 10.1128\/AAC.00035-06","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4161\/viru.22718","article-title":"Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed","volume":"4","author":"Shon AS","year":"2013","unstructured":"Shon AS, Bajwa RP, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence. 2013, 4:107-18. 10.4161\/viru.22718","journal-title":"Virulence"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01019-15","article-title":"Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance","volume":"59","author":"Pitout JD","year":"2015","unstructured":"Pitout JD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother. 2015, 59:5873-84. 10.1128\/AAC.01019-15","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_760_19","article-title":"In vitro evaluation of antibiotic synergy for carbapenem-resistant Klebsiella pneumoniae clinical isolates","volume":"154","author":"Goel A","year":"2021","unstructured":"Goel A, Gupta V, Singhal L, Palta S, Chander J. In vitro evaluation of antibiotic synergy for carbapenem-resistant Klebsiella pneumoniae clinical isolates. Indian J Med Res. 2021, 154:520-6. 10.4103\/ijmr.IJMR_760_19","journal-title":"Indian J Med Res"},{"key":"ref16","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters, version 14.0. (2024). Accessed. July 30, 2025: https:\/\/www.eucast.org\/clinical_breakpoints\/."},{"key":"ref17","article-title":"Performance Standards for Antimicrobial Susceptibility Testing","author":"Clinical and Laboratory Standards Institute","year":"2025","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute, Wayne, PA; 2025."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/515143-checkerboard-insights-diagnostic-integration-of-synergy-testing-for-multidrug-resistant-klebsiella-isolates-in-critical-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T10:20:44Z","timestamp":1786875644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/515143-checkerboard-insights-diagnostic-integration-of-synergy-testing-for-multidrug-resistant-klebsiella-isolates-in-critical-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,16]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.114592","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,16]]}}}